Jacobs Levy Equity Management Inc. grew its position in The Beauty Health Company (NASDAQ:SKIN – Free Report) by 1.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,499,652 shares of the company’s stock after purchasing an additional 27,665 shares during the period. Jacobs Levy Equity Management Inc. owned about 2.02% of Beauty Health worth $3,599,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. SG Americas Securities LLC acquired a new position in Beauty Health in the third quarter worth approximately $37,000. Caprock Group LLC bought a new stake in Beauty Health in the second quarter worth approximately $38,000. Sanctuary Advisors LLC bought a new stake in Beauty Health in the second quarter worth approximately $47,000. Susquehanna Fundamental Investments LLC acquired a new position in shares of Beauty Health during the 2nd quarter worth $105,000. Finally, HighTower Advisors LLC bought a new position in shares of Beauty Health during the 3rd quarter valued at $121,000. 93.26% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
SKIN has been the subject of several recent analyst reports. Piper Sandler reiterated an “underweight” rating and set a $1.00 price target (down previously from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Canaccord Genuity Group upped their target price on Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $2.55.
Beauty Health Stock Up 2.7 %
NASDAQ:SKIN opened at $1.50 on Friday. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23. The Beauty Health Company has a one year low of $0.91 and a one year high of $5.17. The company has a fifty day moving average price of $1.58 and a 200 day moving average price of $1.72.
Beauty Health Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
Read More
- Five stocks we like better than Beauty Health
- ESG Stocks, What Investors Should Know
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- Using the MarketBeat Dividend Yield Calculator
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- How to Invest in Insurance Companies: A Guide
- 10 Safe Investments with High Returns
Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKIN – Free Report).
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.